Discussion
An experimental oral therapy that protects sensitive skin from painful reactions to sunlight is on track toward potential approval in the U.S. The U.S. Food and Drug Administration (FDA) has agreed to review an application seeking approval of the experimental oral therapy dersimelagon as a treatment for two types…